Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31686 | 119 | 28.0 | 41% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3807 | 636 | NEFOPAM//IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AGONIST ANTAGONIST DISCRIMINATION | Author keyword | 3 | 60% | 3% | 3 |
2 | BINDING THERMODYNAMICS | Author keyword | 1 | 11% | 7% | 8 |
3 | W SSM RATS | Author keyword | 1 | 33% | 2% | 2 |
4 | ENZYMATIC ACTIVITY IN SITU | Author keyword | 1 | 50% | 1% | 1 |
5 | H 3 CLOBENPROPIT | Author keyword | 1 | 50% | 1% | 1 |
6 | POLARIZATION AND ELECTRON MICROSCOPY | Author keyword | 1 | 50% | 1% | 1 |
7 | BLUE TETRAZOLIUM | Author keyword | 0 | 33% | 1% | 1 |
8 | DPDPED PEN2 D PEN5ENKEPHALIN | Author keyword | 0 | 33% | 1% | 1 |
9 | H 3 JB93182 | Author keyword | 0 | 33% | 1% | 1 |
10 | THERMODYNAMIC DISCRIMINATION | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2 3 5 6 TETRAMETHYLBENZOQUINONE | 2 | 67% | 2% | 2 |
2 | DRIVEN BINDING | 2 | 67% | 2% | 2 |
3 | FUNDAMENTAL DIFFERENCE | 2 | 26% | 5% | 6 |
4 | DIRECTED ALKYLATING AGENT | 1 | 29% | 2% | 2 |
5 | ADENOSINE A1 RECEPTOR LIGANDS | 1 | 22% | 2% | 2 |
6 | ANTAGONIST INTERACTIONS | 0 | 14% | 3% | 3 |
7 | AGONIST INTERACTIONS | 0 | 20% | 2% | 2 |
8 | DB 2073 | 0 | 20% | 1% | 1 |
9 | MODULATING ACETYLCHOLINE RELEASE | 0 | 20% | 1% | 1 |
10 | SEMIQUINONE FREE RADICALS | 0 | 20% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
(Extra)thermodynamics of the drug-receptor interaction | 1999 | 15 | 10 | 60% |
Receptor binding thermodynamics at the neuronal nicotinic receptor | 2004 | 14 | 21 | 38% |
THERMODYNAMIC ANALYSIS OF THE DRUG-RECEPTOR INTERACTION | 1989 | 45 | 36 | 31% |
OXYGEN RADICALS GENERATION AND DNA SCISSION BY ANTICANCER AND SYNTHETIC QUINONES | 1994 | 21 | 25 | 20% |
CYTOCHROME-P-450 - ACTION OF DRUGS AND POISONS | 1984 | 0 | 2 | 50% |
THE USE OF STABLE NITROXYL RADICALS OF IMIDAZOLINE SERIES | 1983 | 2 | 9 | 44% |
INHIBITORS OF CYTOCHROME P-450S AND THEIR MECHANISM OF ACTION | 1981 | 379 | 17 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NAZL ECCELLENZA SVILUPPO METODOL INNOVAT STUD | 0 | 17% | 0.8% | 1 |
2 | PHARMACEUT CHEM CO DD | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222830 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
2 | 0.0000175720 | ALPHA TOCOPHEROL THERAPY//COMBINATION PATHOGENETIC THERAPY//GRP DEV MOL DIAGNOST IN IDUALIZED THER Y |
3 | 0.0000164562 | TULAREMIA LIVE VACCINE//1 HEXYLCARBAMOYL 5 FLUOROURACIL//5 FLUOROURACIL AND 1 HEXYLCARBAMOYL 5 FLUOROURACIL |
4 | 0.0000127380 | N ALKYLPROTOPORPHYRIN IX//1 AMINOBENZOTRIAZOLE//CHICK EMBRYO LIVER |
5 | 0.0000111325 | AGONIST AFFINITY//OPERATIONAL MODEL OF AGONISM//IRREVERSIBLE RECEPTOR INACTIVATION METHOD |
6 | 0.0000103750 | 3 IMIDAZOLINE 3 OXIDE//3 IMIDAZOLINE//3 IMIDAZOLINE 3 OXIDES |
7 | 0.0000097853 | N 13NH3//NITROGEN 13//MED CHEM NEUROENGN |
8 | 0.0000091152 | CS 670//LOXOPROFEN//ALPHA BETA KETOALKENE |
9 | 0.0000089228 | BISORBICILLINOIDS//TRICHODERMA SP USF 2690//DPPH RADICAL SCAVENGER |
10 | 0.0000083923 | FRIEDEL CRAFTS CYCLIALKYLATION//HETEROPOLYCYCLES//HETEROARYLALKANOLS |